Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomePreferred Shares IssuedShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

vTv Therapeutics (VTVT) Long-Term Debt Issuances: 2013-2023

Historic Long-Term Debt Issuances for vTv Therapeutics (VTVT) over the last 11 years, with Dec 2023 value amounting to $566,000.

  • vTv Therapeutics' Long-Term Debt Issuances fell 99.74% to $13,000 in Q3 2015 from the same period last year, while for Sep 2015 it was $28.9 million, marking a year-over-year change of. This contributed to the annual value of $566,000 for FY2023, which is 27.06% down from last year.
  • Latest data reveals that vTv Therapeutics reported Long-Term Debt Issuances of $566,000 as of FY2023, which was down 27.06% from $776,000 recorded in FY2022.
  • vTv Therapeutics' 5-year Long-Term Debt Issuances high stood at $887,000 for FY2021, and its period low was $500,000 during FY2019.
  • Over the past 3 years, vTv Therapeutics' median Long-Term Debt Issuances value was $776,000 (recorded in 2022), while the average stood at $743,000.
  • Its Long-Term Debt Issuances has fluctuated over the past 5 years, first spiked by 77.40% in 2021, then decreased by 27.06% in 2023.
  • Over the past 5 years, vTv Therapeutics' Long-Term Debt Issuances (Yearly) stood at $500,000 in 2019, then remained steady at $500,000 in 2020, then surged by 77.40% to $887,000 in 2021, then dropped by 12.51% to $776,000 in 2022, then dropped by 27.06% to $566,000 in 2023.